Recent Research
Nelotanserin for Potential Treatment of REM Sleep Behavior Disorder in DLB and PDD
Brief Description of the RVT‐102‐2002 Study Nelotanserin for Potential Treatment of REM Sleep Behavior Disorder in DLB and PDD An estimated 80% of people with dementia with Lewy bodies (DLB) and 60% of people with Parkinson’s disease experience REM sleep
Headache Trials at the RNI
Headaches, particularly migraine headaches, are a major source of misery and disability in our country. They cost employers and insurers literally hundreds of millions of dollars every year in the US alone. We at the RNI have always tried to
This Is MS Awareness Month–MS Treatment
by Vernon Rowe, Doug Schell, and Aaron Seacat March is MS Awareness Month. This time of year we as a country focus on MS, a disease that affects more than 400,000 people in the US and is a major crippler
Lemtrada – A New Multiple Sclerosis Treatment
Lemtrada-A New Multiple Sclerosis Treatment By Leigh Kreshel and Doug Schell A brand new Multiple Sclerosis Treatment is now available. The FDA just approved Lemtrada on November 14th as a multiple sclerosis treatment. Rowe Neurology Institute and some of our
Chronic Insomnia–A Major Health Risk
Insomnia, or problems going to sleep or staying asleep, can become chronic if it lasts more than three months. Anyone who has Chronic Insomnia should see a sleep specialist. Period. Chronic insomnia can lead to depression, decreased job performance, decreased quality
Neurology: Current Clinical Trials Open For Enrollment
New Studies: “Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA” Clinical Coordinator – Leigh Kreshel, MS, CCRC Phone: 913-827-4262, Email: lkreshel@neurokc.com
Individuals with a Sleep-Breathing Disorder May be Impacting Neurons Responsible for Keeping Heart Rate Low
Among the numerous tasks performed by the human brainstem, one of the most vital is that of regulating the body’s cardiovascular system, which relies on neurons based in the brainstem to maintain a low resting heart rate. According to a
Sleep Disorders Research at MANRF
Posters the MidAmerica Research Foundation staff have presented at various conferences. Look for these sleep research posters in the left sidebar: Studying the effects of depression in patients with obstructive sleep apnea. High prevalence of sleep disorders in multiple sclerosis.
MS Research at the Research Foundation
Posters the MidAmerica Research Foundation staff have presented
MANRF Scientist Wins Grant to Study Key Protein
MidAmerica Neuroscience Research Foundation Scientist Believes Specific Protein Might Hold The Key